Sat Kartar Life Share Price | Sat Kartar Life Stock Screener
SATKARTAR
Pharmaceuticals
Track Sat Kartar Life share price live with TickJournal's free stock screener.
Check SATKARTAR 52-week high low for the annual price range and momentum.
Use the Sat Kartar Life stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sat Kartar Life Market Cap
₹296.00 Cr.
SATKARTAR P/E Ratio (TTM)
-
Sat Kartar Life P/B Ratio
4.27
EPS (TTM)
₹10.96
Dividend Yield
-
Debt to Equity
0.13
SATKARTAR 52 Week High
-
Sat Kartar Life 52 Week Low
-
Operating Margin
-
Profit Margin
-
SATKARTAR Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹64.00
Total Equity
₹52.00
Sat Kartar Life Share Price Chart
Screen Sat Kartar Life share price with an interactive chart. Analyse SATKARTAR price trends and volatility across different timeframes.
Sat Kartar Life Company Profile - Fundamental Screener
Screen Sat Kartar Life company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SATKARTAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0NB801022
Sat Kartar Life Balance Sheet Screener
Screen SATKARTAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 64 | 22 | 15 | 12 |
| Current Assets | 55 | 12 | 6 | 7 |
| Fixed Assets | 6 | 3 | 4 | 3 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 2 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 52 | 9 | 3 | 1 |
| Share Capital | 16 | 3 | 1 | 1 |
| Reserves & Surplus | 36 | 7 | 3 | 0 |
Sat Kartar Life Income Statement Screener - Profit & Revenue Analysis
Screen Sat Kartar Life income statement and profit fundamentals.
Analyze SATKARTAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sat Kartar Life share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 194 | 164 | 128 | 83 | 52 |
| Expenses | 0 | 169 | 149 | 118 | 78 | 50 |
| EBITDA | 0 | 25 | 15 | 10 | 5 | 3 |
| Operating Profit % | 0.00% | 13.00% | 9.00% | 8.00% | 6.00% | 4.00% |
| Depreciation | 0 | 3 | 1 | 1 | 1 | 1 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 23 | 13 | 9 | 3 | 2 |
| Tax | 0 | 6 | 3 | 2 | 1 | 0 |
| Net Profit | 0 | 17 | 10 | 6 | 3 | 1 |
| EPS | 0.00 | 10.96 | 7.37 | 22.52 | 3.58 | 1.98 |
Sat Kartar Life Cash Flow Screener - Liquidity Fundamentals
Screen SATKARTAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | -5 | 7 |
| Investing Activities | 0 | -3 |
| Financing Activities | 34 | -3 |
| Net Cash Flow | 28 | 2 |
Sat Kartar Life Shareholding Pattern Screener
See Sat Kartar Life shareholding pattern with promoter, FII, and DII holdings.
Check Sat Kartar Life promoter holding and ownership changes for SATKARTAR on TickJournal.
| Item | 2026-Mar | 2025-Jan | 2025-Mar | 2025-Sept | 2024-Jul |
|---|---|---|---|---|---|
| Promoter Holding | 63.62% | 63.31% | 63.34% | 63.43% | 85.72% |
| FII Holding | 0.13% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 2.26% | 1.89% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.29% | 19.23% | 17.81% | 24.41% | 13.45% |
| Other Holding | 6.71% | 15.57% | 18.85% | 12.16% | 0.83% |
| Shareholder Count | 846 | 1,311 | 425 | 717 | 28 |
Sat Kartar Life Share Dividend Screener - Share Yield Analysis
Check Sat Kartar Life dividend history with payout and yield data.
View Sat Kartar Life dividend details including ex-dates and amounts for SATKARTAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.70 | 0.47% |
| 2024-March | ₹0.70 | 0.46% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sat Kartar Life Stock Index Membership
See which indices include Sat Kartar Life stock.
Check SATKARTAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sat Kartar Life Market Events Screener - Corporate Actions
Get Sat Kartar Life corporate actions including splits, bonuses, and buybacks.
Check Sat Kartar Life stock events that may affect SATKARTAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-13 | 2026-05-13 | Extraordinary General Meeting | NA | 3.73% |
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | -1.63% |
| 2026-01-05 | 2026-01-05 | Change Of Name | NA | 0.00% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | 5.20% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 0.70 /share | -1.81% |
| 2025-05-17 | 2025-05-17 | Quarterly Result Announcement | NA | 13.56% |
Sat Kartar Life Competitors Screener - Peer Comparison
Screen SATKARTAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,509 | 38.37 | 58,220 | 6.38% | 11,565 | 54.66 |
| Divis Laboratories | 180,452 | 69.82 | 10,560 | 8.73% | 2,520 | 59.28 |
| Torrent Pharmaceuticals | 153,580 | 70.46 | 13,753 | 19.18% | 2,028 | 60.91 |
| Cipla | 114,559 | 29.64 | 27,712 | -2.46% | 3,783 | 64.86 |
| Dr Reddys Laboratories | 110,089 | 26.69 | 33,593 | -0.44% | 3,998 | 54.22 |
| Zydus Life Science | 109,257 | 21.19 | 26,720 | 13.65% | 5,242 | 75.42 |
| Lupin | 104,041 | 19.33 | 27,488 | 19.98% | 5,345 | 46.91 |
| Mankind Pharma | 99,915 | 51.52 | 14,278 | 12.03% | 1,750 | 55.29 |
| Aurobindo Pharma | 83,397 | 24.27 | 33,385 | 3.21% | 3,376 | 47.24 |
| Laurus Labs | 74,592 | 83.31 | 6,813 | 21.03% | 884 | 80.70 |
Sat Kartar Life Company Announcements - News Screener
Screen SATKARTAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.